| Jay H Globerson, MD | |
|
16001 W 9 Mile Rd, Southfield, MI 48075-4818 | |
| (248) 849-3000 | |
| Not Available |
| Full Name | Jay H Globerson |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 41 Years |
| Location | 16001 W 9 Mile Rd, Southfield, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285677047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 4301047462 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
| Mclaren Northern Michigan | Petoskey, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northern Anesthesia Providers Pc | 4789579863 | 23 |
| Northland Anesthesia Associates Pc | 5294623336 | 21 |
| Providence Park Anesthesia Associates, Pc | 7315009479 | 22 |
News Archive
The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees - more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.
› Verified 1 days ago
| Entity Name | Northland Anesthesia Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528001880 PECOS PAC ID: 5294623336 Enrollment ID: O20040309001092 |
News Archive
The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees - more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.
› Verified 1 days ago
| Entity Name | Northern Anesthesia Providers Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396834628 PECOS PAC ID: 4789579863 Enrollment ID: O20060405000243 |
News Archive
The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees - more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.
› Verified 1 days ago
| Entity Name | Providence Park Anesthesia Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942459672 PECOS PAC ID: 7315009479 Enrollment ID: O20081224000115 |
News Archive
The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees - more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay H Globerson, MD 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Jay H Globerson, MD 16001 W 9 Mile Rd, Southfield, MI 48075-4818 Ph: (248) 849-3000 |
News Archive
The global interest for research in palliative care is increasing rapidly and The 6th Research Congress of the EAPC reflects this with a record number of abstracts and attendees - more than 660 abstracts from 39 different countries will be presented to over 1200 international researchers and clinicians.
A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.
Angiochem, a clinical stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB), announced that the complete analysis results of a Phase 2 clinical study with ANG1005, a novel paclitaxel-peptide drug conjugate, in breast cancer patients with brain metastasis were presented today at the 2013 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.
In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.
› Verified 1 days ago
Jonathan Arie Kroll, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Dominick Lago Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Jeffrey Joseph Kirouac, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Leslie A Mumaw, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26051 Lahser Rd, Southfield, MI 48034 Phone: 248-223-9945 | |
Mark Mounayer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26025 Lahser Rd Fl 3, Southfield, MI 48033 Phone: 248-663-1900 Fax: 248-663-1901 | |
Dr. Alexander Grossi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075 Phone: 734-233-8481 | |
Shad Siddiqi, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22250 Providence Dr Ste 401, Southfield, MI 48075 Phone: 866-974-2673 Fax: 866-939-2673 |